PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 22 filers reported holding PDL BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,760,000 | 0.0% | 37,000 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $3,760,000 | +9300.0% | 37,000 | 0.0% | 0.02% | – |
| Q3 2020 | $40,000 | +2.6% | 37,000 | 0.0% | 0.00% | – |
| Q2 2020 | $39,000 | 0.0% | 37,000 | 0.0% | 0.00% | – |
| Q1 2020 | $39,000 | -2.5% | 37,000 | 0.0% | 0.00% | – |
| Q4 2019 | $40,000 | +11.1% | 37,000 | 0.0% | 0.00% | – |
| Q3 2019 | $36,000 | -5.3% | 37,000 | 0.0% | 0.00% | – |
| Q2 2019 | $38,000 | – | 37,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 9,937,000 | $9,552,000 | 20.97% |
| Pinnacle Holdings, LLC | 2,170,000 | $2,069,733,000 | 0.78% |
| Context Capital Management, LLC | 700,000 | $674,000 | 0.38% |
| Soros Fund Management | 8,733,000 | $8,439,000 | 0.23% |
| LINDEN ADVISORS LP | 16,117,000 | $15,504,000 | 0.21% |
| SG Americas Securities, LLC | 140,000 | $13,528,000 | 0.11% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,000,000 | $4,854,000 | 0.06% |
| THRIVENT FINANCIAL FOR LUTHERANS | 1,700,000 | $1,634,000 | 0.01% |
| SANDERS MORRIS HARRIS LLC | 13,000 | $12,000 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $2,403,000 | 0.00% |